Fiona E Smyth

Fiona E Smyth

UNVERIFIED PROFILE

Are you Fiona E Smyth?   Register this Author

Register author
Fiona E Smyth

Fiona E Smyth

Publications by authors named "Fiona E Smyth"

Are you Fiona E Smyth?   Register this Author

23Publications

648Reads

48Profile Views

Impact on product quality of high productive GS-CHO cell lines.

BMC Proc 2011 22;5 Suppl 8:P17. Epub 2011 Nov 22.

Ludwig Institute for Cancer Research, Melbourne-Austin Branch, Heidelberg, Victoria, 3084, Australia.

View Article

Download full-text PDF

Source
https://bmcproc.biomedcentral.com/articles/10.1186/1753-6561
Publisher Site
http://dx.doi.org/10.1186/1753-6561-5-S8-P17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284987PMC
April 2015

Evaluation of an online biomass probe to monitor cell growth and cell death.

BMC Proc 2011 22;5 Suppl 8:P16. Epub 2011 Nov 22.

Ludwig Institute for Cancer Research, Melbourne-Austin Branch, Heidelberg, Victoria, 3084, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1753-6561-5-S8-P16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284924PMC
April 2015

Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.

Prostate 2009 Jan;69(1):92-104

Tumour Targeting Laboratory, Ludwig Institute for Cancer Research, Melbourne Centre for ClinicalSciences, Austin Hospital, Heidelberg, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.20856DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597150PMC
January 2009

Tumor targeting by a multivalent single-chain Fv (scFv) anti-Lewis Y antibody construct.

Cancer Biother Radiopharm 2008 Aug;23(4):411-23

Tumour Targeting Program, Ludwig Institute for Cancer Research, Austin Hospital, Heidelberg, Victoria, Australia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663784PMC
http://dx.doi.org/10.1089/cbr.2007.0450DOI Listing
August 2008

Radioimmunotherapy with alpha-particle emitting 213Bi-C-functionalized trans-cyclohexyl-diethylenetriaminepentaacetic acid-humanized 3S193 is enhanced by combination with paclitaxel chemotherapy.

Clin Cancer Res 2007 Sep;13(18 Pt 2):5604s-5612s

Tumour Targeting Program, Ludwig Institute for Cancer Research, Austin Hospital, Heidelberg, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-1071DOI Listing
September 2007

Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model.

J Nucl Med 2006 Apr;47(4):716-25

Tumour Targeting Program, Ludwig Institute for Cancer Research, Austin Hospital, Heidelberg, Victoria 3084, Australia.

View Article

Download full-text PDF

Source
April 2006

Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in mice.

Proc Natl Acad Sci U S A 2005 Dec 19;102(52):19051-6. Epub 2005 Dec 19.

Cancer Immunology Program and Department of Hematology and Medical Oncology, Peter MacCallum Cancer Centre, St. Andrew's Place, Melbourne, Victoria 3002, Australia.

View Article

Download full-text PDF

Source
http://www.pnas.org/cgi/doi/10.1073/pnas.0504312102
Publisher Site
http://dx.doi.org/10.1073/pnas.0504312102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1323148PMC
December 2005

Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma.

Cancer Immun 2005 Feb 22;5. Epub 2005 Feb 22.

Ludwig Institute for Cancer Research, Melbourne Tumour Biology Branch, Austin Hospital, Heidelberg, Victoria, 3084, Australia.

View Article

Download full-text PDF

Source
February 2005

Generation of anti-idiotype antibodies for application in clinical immunotherapy laboratory analyses.

Hybrid Hybridomics 2003 Aug;22(4):219-28

Tumor Targeting Laboratory, Ludwig Institute for Cancer Research, Melbourne Tumor Biology Branch, Austin & Repatriation Medical Centre, 145-164 Studley Road, Heidelberg, Victoria 3084, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/153685903322328947DOI Listing
August 2003

Targeting primary human Ph(+) B-cell precursor leukemia-engrafted SCID mice using radiolabeled anti-CD19 monoclonal antibodies.

J Nucl Med 2003 Jul;44(7):1105-12

Ludwig Institute For Cancer Research, Melbourne Tumour Biology Branch, Austin and Repatriation Medical Centre, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
July 2003

Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871.

Cancer Immun 2002 Oct 7;2:13. Epub 2002 Oct 7.

Ludwig Institute for Cancer Research, Melbourne Tumour Biology Branch, Austin and Repatriation Medical Centre, Heidelberg, Victoria, 3084, Australia.

View Article

Download full-text PDF

Source
October 2002

Anti-renal cell carcinoma chimeric antibody G250: cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity.

Cancer Immunol Immunother 2002 May 1;51(3):171-7. Epub 2002 Mar 1.

Tumour Targeting Program, Ludwig Institute for Cancer Research, Melbourne Branch, Austin and Repatriation Medical Centre, Heidelberg, Victoria 3084, Australia.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00262-002-0268-4
Publisher Site
http://dx.doi.org/10.1007/s00262-002-0268-4DOI Listing
May 2002